USPTO serial 75142235
PHI-TEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALEMI, DOMINICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHI-TEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kyoto city, Kyoto Pref., JP
Kyoto city, Kyoto Pref., JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STACEY R HALPERN
JEFFREY L VAN HOOSEAR KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN ST 14TH FLIRVINE, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | drugs for medical purposes, namely, drugs for central nervous system, namely, general anesthetics, hypnotics and sedatives, anti-epileptics, antipyretics and analgesics, nervous system stimulants, analeptics and anti-dizziness agents; drugs for peripheral nervous system, namely, local anesthetics, skeletal muscle relaxants, autonomics, antispasmodics, diaphoretics and anhidrotics; drugs for sensory organs, namely, agents for ophthalmic use and agents for optic and nasal use; drugs used in allergy, namely, anti-histamines and agents for stimulation therapy; drugs affecting circulatory organs, namely, cardiotonics, agents for arrhythmia, diuretics, hypo tensors, vasosupporters, vasoconstrictors and cerebral hemorrhage prophylactic; agents affecting respiratory organs, namely, respiratory stimulants, antitussives and expectorants and cough wheat gluten; agents for digestive organs, namely, organs for dental use, agents for oral use, stomachics and digestives, antacids, anti-emetics, emetics, choleretics, antidiarrheals, purgatives, clysters, stomach and bowels wash powder, tooth prophylactic, stomatic refrigerant, and stomatic cleanser; hormone preparations, namely, pituitary hormone preparations, salivary gland hormone preparations, thyroid and accessory thyroid hormone preparations, pancreas hormone preparations, adrenal hormone preparations, androgens, estrogens and mixed hormone preparations; agents for urinary, genital and anal organs, namely, urinary antiseptics, oxytocics, agents affecting menstruation, contraceptives and anti-hemorrhoidics; agents affecting epidermis, namely, disinfectants, dermatics for purulence, analgesics, anti-itchings, astringents, cataplasms, anti-dermoinfectives, corrosives, hair remedies, bath preparations, medicated baby powder, medicated baby oil, medicated soap of the Japanese pharmacopoeia; vitamin preparations, namely, vitamin A preparations, vitamin B preparations, vitamin C preparations, vitamin D preparations, composite vitamin preparations compounded of water soluble and fat soluble vitamins, mixed vitamin preparations compounded of water soluble and fat soluble vitamins and cod-liver oil drops; amino acids and preparations, namely, lysine, methionin, tryptophane and threonine; preparations, nutrients, tonics and alternatives, namely, calcium, mineral, saccharide, organic acid, proteins, amino acids, organotherapeutics, chondroitin, foodstuff solidifying agent, medicated wine and royal jelly; agents relating to blood, namely, blood substitutes, hemostatics, anticoagulants and blood-plasma; agents affecting metabolism, namely, lipotropic factor preparations, antidotes, agents for treatment of habitual intoxication, lactogoques and enzyme preparations; agents for activating cellular function, namely, chlorophyll preparations and dyes; anti-cancer and anti-sarcoma tumor suppressing agents; agents used in lesion due to physical stimuli, namely, agents used in thermoplegia and agents used in radiation sickness; agents used in lesion due to chemical stimuli, namely, anti-benzolismus, anti-arsenium and anti-chlorine poisoning; antibiotics and preparations, namely, penicillin, streptomycin, chloramphenicol, erythromycin, thiolutin, tetracycline, colistin-polymyxin, mixed antibiotic, salkomycin and trichomycin; chemotherapeutics agents and preparations, namely, sulfonamide, antituberculotic, antisyphilitics and antiliprotic; biological products, namely, vaccines, toxins, toxoids, antitoxins, antibacterial sera, diagnostic acids for biological tests and mixed biological preparations; agents against parasites, namely, antiprozoals and anthelmintics; agents for dispensing use, namely, excipients, ointment bases, solvents, flavoring agents, room deodorizer and medical coloring agents; labeled isotope substance for treatment and diagnosis; narcotics, namely, opium alkaloids, derivatives and preparations, coca alkaloids, derivatives and preparations and synthetic narcotics; veterinary drugs, namely, vaccines, pain relief medication and preparations for treatment of intestinal bacteria; agents for agriculture or public health, namely, disinfectants, insecticides, fumigants, rodenticides, herbicides, germination controllers, hormones for plants, plant rearing agents, soil improving agents, moth repellents, room deodorants and antiseptics; dental restoration compounds, namely, dental cements, dental prosthetic and filling materials; oblates, namely, thin wafers made from wheat meal or capsules for the purpose of wrapping the aforementioned drugs for medical purposes; gauze; capsules for containing aforementioned drugs for medical purposes; ear bandages; menstruation tampons; sanitary napkins; panties incorporating sanitary pads; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid wound dressings; adult diapers; semen for artificial insemination; powdered milk for babies; menstruation bandages | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 20, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 19, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 26, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 6, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 9, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 7, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 20, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2005 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 14, 2005 | ALIE | ASSIGNED TO LIE | — |
| Nov 16, 2004 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 4, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2004 | PETG | PETITION TO REVIVE-GRANTED | — |
| Nov 4, 2004 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 15, 2004 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 15, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 19, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 19, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2004 | PAPER RECEIVED | — | |
| Oct 23, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Oct 9, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 25, 2003 | PAPER RECEIVED | — | |
| Dec 16, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 26, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2002 | PAPER RECEIVED | — | |
| Aug 5, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jul 8, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| May 20, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2001 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 26, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2001 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Mar 29, 2001 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Dec 1, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 14, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2000 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Sep 21, 1999 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 29, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 5, 1999 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 9, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 1998 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| May 20, 1998 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 3, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 1997 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 1997 | DOCK | ASSIGNED TO EXAMINER | — |